We are live on ! Find out more
PCM

Patient Capital Management Portfolio holdings

AUM $2.74B
1-Year Est. Return 43.59%
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
+43.59%
3 Year Est. Return
+124.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$206M
AUM Growth
+$5.56M
Cap. Flow
+$5.34M
Cap. Flow %
2.59%
Top 10 Hldgs %
41.54%
Holding
45
New
3
Increased
11
Reduced
15
Closed
2

Top Buys

Rank Stock Value
1
SI
Silvergate Capital Corporation
SI
+$5.38M
2
GOOS
Canada Goose Holdings
GOOS
+$3.5M
3
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
+$2.22M
4
EXE
Expand Energy Corp
EXE
+$1.59M
5
PTON icon
Peloton Interactive
PTON
+$959K

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$2.99M
2
FANG icon
Diamondback Energy
FANG
+$2.34M
3
CLF icon
Cleveland-Cliffs
CLF
+$1.32M
4
BHC icon
Bausch Health
BHC
+$1.29M
5
ADT icon
ADT
ADT
+$942K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 32.4%
2 Financials 17.44%
3 Energy 13.02%
4 Technology 10.53%
5 Industrials 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXE
26
Expand Energy Corp
EXE
$21.6B
$3.59M 1.74%
38,000
+16,000
+73% +$1.59M
RKT icon
27
Rocket Companies
RKT
$38B
$3.55M 1.73%
507,700
-30,000
-6% -$219K
KRTX
28
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$3.48M 1.69%
17,700
– –
ADT icon
29
ADT
ADT
$5.59B
$3.44M 1.67%
379,800
-105,900
-22% -$942K
COIN icon
30
Coinbase
COIN
$40.1B
$2.81M 1.37%
79,500
+10,000
+14% +$527K
QUOT
31
DELISTED
Quotient Technology Inc
QUOT
$2.81M 1.36%
819,400
-86,600
-10% -$245K
COF icon
32
Capital One
COF
$133B
$2.67M 1.3%
28,700
– –
SI
33
DELISTED
Silvergate Capital Corporation
SI
$2.36M 1.15%
+135,600
New +$5.38M
SOFI icon
34
SoFi Technologies
SOFI
$23.5B
$2.17M 1.05%
469,700
– –
SFIX
35
Stitch Fix
SFIX
$556M
$2.06M 1%
662,350
– –
COIN icon
36
CALL
Coinbase
COIN
$40.1B
$1.82M 0.88%
51,500
– –
FANG icon
37
Diamondback Energy
FANG
$52.7B
$1.75M 0.85%
12,800
-16,000
-56% -$2.34M
PGEN icon
38
Precigen
PGEN
$2.57B
$1.21M 0.59%
798,200
+500,000
+168% +$860K
LEN.B icon
39
Lennar Class B
LEN.B
$20.9B
$935K 0.45%
13,150
– –
BAC icon
40
Bank of America
BAC
$441B
$828K 0.4%
25,000
– –
PTON icon
41
Peloton Interactive
PTON
$2.42B
$794K 0.39%
+100,000
New +$959K
VNT icon
42
Vontier
VNT
$4.98B
$773K 0.38%
40,000
-25,000
-38% -$469K
BHC icon
43
Bausch Health
BHC
$2.26B
– –
-187,600
Closed -$1.29M
BRLT icon
44
Brilliant Earth
BRLT
$20.5M
– –
-75,000
Closed -$430K
1
2

Similar funds

CIAS
CBIZ Investment Advisory Services Independence, Ohio $2.74B AUM 14.19% 1-Year Est. Return
LMIM
Lockheed Martin Investment Management Bethesda, Maryland $2.73B AUM 28.24% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
CC
Cartenna Capital Stamford, Connecticut $2.74B AUM 44.46% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

Patient Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Patient Capital Management held 45 positions worth $206M, up 2.8% from $200M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Patient Capital Management's Q4 2022 filing shows 3 new, 11 increased, 15 reduced and 2 closed positions. Its largest new stake was Silvergate Capital Corporation: 135,600 shares worth $2.36M. The largest sale was Teva Pharmaceuticals, an estimated $2.99M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 32% of assets, up from 31% a quarter earlier, followed by Financials and Energy.

  • Patient Capital Management's largest Q4 2022 buy was Silvergate Capital Corporation: 135,600 shares worth $2.36M.
  • Patient Capital Management added most to Canada Goose Holdings in Q4 2022, an estimated $3.5M increase.
  • Patient Capital Management's biggest Q4 2022 reduction was Teva Pharmaceuticals, cutting an estimated $2.99M.
  • Patient Capital Management fully exited Bausch Health in Q4 2022, selling an estimated $1.29M.
  • Patient Capital Management's ten largest holdings make up 42% of its $206M portfolio in Q4 2022.
  • Patient Capital Management opened 3 new positions and closed 2 in Q4 2022.
  • Patient Capital Management's portfolio value rose 2.8% quarter-over-quarter to $206M.

Based on Patient Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.